Cargando…
Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid
BACKGROUND: Alzheimer's disease (AD) and cerebrovascular disease (CVD) including chronic small vessel disease of the brain (SVD) are the most frequent causes of dementia. AD is associated with metabolism of amyloid precursor protein (APP) and low levels of amyloid-β peptide (Aβ) X-42 in the cer...
Autores principales: | Selnes, Per, Blennow, Kaj, Zetterberg, Henrik, Grambaite, Ramune, Rosengren, Lars, Johnsen, Lisbeth, Stenset, Vidar, Fladby, Tormod |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921347/ https://www.ncbi.nlm.nih.gov/pubmed/20673341 http://dx.doi.org/10.1186/1743-8454-7-10 |
Ejemplares similares
-
Cerebrospinal fluid markers in Creutzfeldt-Jakob disease
por: Skinningsrud, Anders, et al.
Publicado: (2008) -
Correlates of Subjective and Mild Cognitive Impairment: Depressive Symptoms and CSF Biomarkers
por: Grambaite, Ramune, et al.
Publicado: (2013) -
Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline
por: Eliassen, Carl F., et al.
Publicado: (2017) -
Cerebrospinal Fluid Levels of Amyloid Beta 1-43 Mirror 1-42 in Relation to Imaging Biomarkers of Alzheimer’s Disease
por: Almdahl, Ina S., et al.
Publicado: (2017) -
Stable cerebrospinal fluid neurogranin and β-site amyloid precursor protein cleaving enzyme 1 levels differentiate predementia Alzheimer’s disease patients
por: Kirsebom, Bjørn Eivind, et al.
Publicado: (2022)